Endometrial cancer laboratory findings

	Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer laboratory findings On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer laboratory findings
CDC on Endometrial cancer laboratory findings
Endometrial cancer laboratory findings in the news
Blogs on Endometrial cancer laboratory findings
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer laboratory findings

The tumor marker CA-125 is sometimes checked, since this can predict advanced stage disease.^[1]

References

↑ Dotters DJ. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 2000;182:1328-34. PMID 10871446.